Riskpilot← Back to searchSign inGet full accessPharmakea AB
ABActiveOrg 5590018288Ruddammsgatan 32Business and other management consultancy activities · NACE 7020Est. 20150 employees
Revenue 2025
SEK 249K
+19% vs 2024
EBITDA margin
65.5%
+112% vs 2024
Equity ratio
31.2%
Financial strength
Net profit 2025
SEK 54K
+80% vs 2024
| Revenue | SEK 249K | +19% |
| EBITDA | SEK 163K | +112% |
| Net profit | SEK 54K | +80% |
| Total assets | SEK 452K | -16% |
| Equity | SEK 141K | +60% |
| Employees | 0 | — |
Legal name
Pharmakea AB
Org number
5590018288
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
27 januari 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva försäljning av tjänster och produkter inom friskvårds-, omsorgs- och vårdverksamheterna samt därtill köp samt försäljning av bolag och immaterialrätter. Konsultverksamhet riktad huvudsakligen till små- och medelstora företag och privatpersoner och institutioner. Reklam, medieproduktion och fotokonst, digital bildframställning, konsthantverk och andra presentartiklar och därmed förenlig verksamhet.
Address
Ruddammsgatan 32
Email
jason.chen@eacc.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 275 | 0 | 210 | 249 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −150 | 120 | −98 | 77 | 163 |
| Depreciation & amort. | −80 | −80 | −150 | −47 | −110 |
| EBIT | −230 | 40 | −248 | 30 | 53 |
| Net financials | — | — | — | — | — |
| Profit before tax | −230 | 40 | −248 | 30 | 54 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −230 | 40 | −248 | 30 | 54 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 750 | 665 | 449 | 535 | 452 |
| Equity | 66 | 106 | 58 | 88 | 141 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 684 | 559 | 392 | 448 | 311 |
| Total debt | 684 | 559 | 392 | 448 | 311 |
EBITDA margin
65.5%
This company
15.8%
Market median
+315% vs market
20212025
Equity ratio
31.2%
This company
38.2%
Market median
+18% vs market
20212025
Return on equity
38.3%
This company
18.4%
Market median
+108% vs market
20212025
Net profit margin
21.7%
This company
8.1%
Market median
+168% vs market
20212025
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
20212025
Debt / equity
2.21×
This company
0.62×
Market median
-256% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharmakea AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ning Chen | Deputy Board Member | 0 companies |
| Jason Jiayu Chen | Board of Directors | 0 companies |